Guardian Pharmacy Services, Inc. (GRDN)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 500M 1B 1.5B Q4 '24: 1.2B Q1 '25: 1.3B Q2 '25: 1.3B Q3 '25: 1.4B Q4 '25: 1.4B Q1 '26: 1.5B Q2 '26: 1.5B Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit TTM

0 150M 300M 450M Q4 '24: 244.4M Q1 '25: 253.6M Q2 '25: 260.5M Q3 '25: 274.3M Q4 '25: 292.7M Q1 '26: 304.7M Q2 '26: 316.6M Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Income TTM

-90M -60M -30M 0 30M 60M 90M Q4 '24: -62.9M Q1 '25: -57.8M Q2 '25: -62.3M Q3 '25: 58.7M Q4 '25: 72.7M Q1 '26: 77.4M Q2 '26: 85.4M Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income TTM

-120M -80M -40M 0 40M 80M 120M Q4 '24: -110M Q1 '25: -107.7M Q2 '25: -98.7M Q3 '25: 33.1M Q4 '25: 49.2M Q1 '26: 53.1M Q2 '26: 65.9M Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue TTM

0 400M 800M 1.2B Q4 '24: 984M Q1 '25: 1B Q2 '25: 1.1B Q3 '25: 1.1B Q4 '25: 1.2B Q1 '26: 1.2B Q2 '26: 1.1B Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow TTM

0 35M 70M 105M Q4 '24: 58M Q1 '25: 66.9M Q2 '25: 57.7M Q3 '25: 88M Q4 '25: 100.3M Q1 '26: 88.8M Q2 '26: 98.9M Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.